Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome

Maria Fleseriu, Beverly M.K. Biller, James W. Findling, Mark E. Molitch, David E. Schteingart, Coleman Gross

Research output: Contribution to journalArticlepeer-review

296 Scopus citations

Fingerprint

Dive into the research topics of 'Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds